All Government Grants
Advanced Search & Filters
An Integrated Eastern Ontario Business Incubator and Accelerator Major Funding
Invest Ottawa (2013)
Ottawa, ON 2018-19
The objective of the project is to build an integrated incubation and acceleration program, which will provide high potential SMEs from Eastern Ontar…
$10,045,559
Canada Accelerator and Incubator Program
Enablement of SMB omni channel advertisement platform Major Funding
ILLUMIN INC.
Toronto, ON 2023-24
Research and development of an omni-channel advertising platform and internal business processes designed specifically to address the advertising nee…
$10,000,000
Industrial Research Assistance Program …
April 1, 2023 - Dec. 31, 2024COVID-19 Vaccine: Phase 3 Clinical Trial of DNA-Based Vaccine Booster Covigenix… Major Funding
Entos Pharmaceuticals Inc.
Edmonton, AB 2023-24
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In t…
$10,000,000
Industrial Research Assistance Program …
Sept. 1, 2022 - March 31, 2024Hybrid Integration Platform Major Funding
Solace Corporation
Ottawa, ON 2023-24
A project to create an event-enabled, edge-supporting, integration and API management platform that supports modern, real-time, distributed, decouple…
$10,000,000
Industrial Research Assistance Program …
May 1, 2023 - April 30, 2026COVID-19 Response (TI): antivrial & Inflammation Controlling Therapeutic Drug C… Major Funding
Laurent Pharmaceuticals Inc.
Montreal, QC 2021-22
Clinical development of LAU-7b antiviral and inflammation-controlling therapy for COVID-19 infection.
$10,000,000
Industrial Research Assistance Program …
Oct. 1, 2020 - Dec. 31, 2022COVID-19 Vaccine: Phase 1 clinical trial of DNA-based vaccine Covigenix VAX-001 Major Funding
Entos Pharmaceuticals Inc.
Edmonton, AB 2021-22
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In t…
$10,000,000
Industrial Research Assistance Program …
Sept. 1, 2020 - Aug. 31, 2021COVID-19 Vaccine: Phase 1 clinical trial of DNA-based vaccine Covigenix VAX-001 Major Funding
Entos Pharmaceuticals Inc.
Edmonton, AB 2021-22
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In t…
$10,000,000
Industrial Research Assistance Program …
Sept. 1, 2020 - July 31, 202110x Improved Gas Oscillation Super Plastic Forming (GO-SPF) Technology Adoption Major Funding
Macrodyne Technologies Inc.
Concord, ON 2024-25
Development of advanced superplastic forming technology which uses Gas Oscillation to drastically (up to 10x) increase the speed of forming, moving …
$10,000,000
Industrial Research Assistance Program …
May 1, 2024 - March 31, 2027Providence COVID-19 Vaccine Development - Stage 2 Major Funding
Providence Therapeutics Holdings Inc.
Calgary, AB 2021-22
The Firm is Canada's leader in mRNA therapeutics and this project's main goal is to continue the development of PTX-COVID19-B by conducting a Phase I…
$8,660,000
Industrial Research Assistance Program …
July 23, 2021 - Nov. 30, 2022Providence COVID-19 Vaccine Development - Stage 2 Major Funding
Providence Therapeutics Holdings Inc.
Calgary, AB 2021-22
The Firm is Canada's leader in mRNA therapeutics and this project's main goal is to continue the development of PTX-COVID19-B by conducting a Phase I…
$8,600,000
Industrial Research Assistance Program …
July 23, 2021 - Nov. 30, 2022Deploy & Operate Major Funding
Vention inc.
Montreal, QC 2023-24
Build & Operate will create the software necessary to automate production using a number of third-party collaborative robots on manufacturing floors,…
$7,700,000
Industrial Research Assistance Program …
May 1, 2022 - May 31, 2024COVID-19 - A toolbox for the production of nucleic acid products for vaccines a… Major Funding
NORTHERN RNA INC.
Calgary, AB 2023-24
The COVID-19 pandemic has impacted the global supply of nucleic acid products including mRNA and plasmid DNA and delivery vehicles such as lipid nano…
$7,000,000
Industrial Research Assistance Program …
July 28, 2022 - March 22, 2024LAU-7b as next-generation COVID-19 therapeutic - COVID-19 Response-Stage 3 (TI)… Major Funding
Laurent Pharmaceuticals Inc.
Montreal, QC 2024-25
#####################################################################################################################################################…
$7,000,000
Industrial Research Assistance Program …
Feb. 1, 2023 - March 31, 2025Introhive Expansion into the Financial Services (FS), Technology, Media and Tel… Major Funding
Introhive Services Inc.
Fredericton, NB 2021-22
Design and development to accelerate innovation and leverage AI, for transformative expansion of Introhive into three new industry segments: 1) Finan…
$6,670,000
Industrial Research Assistance Program …
Nov. 1, 2021 - March 24, 2023COVID-19 Response (TI): antivrial & Inflammation Controlling Therapeutic Drug C… Major Funding
Laurent Pharmaceuticals Inc.
Montreal, QC 2021-22
Clinical development of LAU-7b antiviral and inflammation-controlling therapy for COVID-19 infection.
$6,425,932
Industrial Research Assistance Program …
Oct. 1, 2020 - March 31, 2022COVID-19 VI Providence Major Funding
Providence Therapeutics Holdings Inc.
Calgary, AB 2021-22
Providence Therapeutics, Canadas leading mRNA vaccine manufacture, is manufacturing an mRNA vaccine against COVID-19. The company is in the R&D phase…
$6,400,000
Industrial Research Assistance Program …
Sept. 1, 2020 - July 30, 2021COVID-19 VI Providence Major Funding
Providence Therapeutics Holdings Inc.
Calgary, AB 2021-22
Providence Therapeutics, Canadas leading mRNA vaccine manufacture, is manufacturing an mRNA vaccine against COVID-19. The company is in the R&D phase…
$6,400,000
Industrial Research Assistance Program …
Sept. 1, 2020 - July 30, 2021In-Sec-M Cyber security services to SMEs Major Funding
In-Sec-M, Security Research and Innovation
Gatineau, QC 2021-22
The project aims to support and increase the cyber security posture of innovative Canadian SMEs of all sector of activities that requires diligence i…
$6,370,000
Industrial Research Assistance Program …
April 5, 2020 - March 31, 2023COVID-19 Rapid Response: Identifying & developing next-generation COVID-19 ther… Major Funding
AbCellera Biologics Inc.
Vancouver, BC 2023-24
Identify and develop antibody therapeutics for response and preparedness against COVID-19, and expand capacity for rapid development and delivery of …
$6,325,000
Industrial Research Assistance Program …
Nov. 1, 2022 - March 31, 2024Innovative, Sustainable, and Economic Brine-to-Battery Lithium Extraction and R… Major Funding
Saltworks Technologies Inc.
Richmond, BC 2023-24
The project will develop sustainable and economic lithium processing technology that will contribute to addressing lithium supply challenges. Battery…
$6,200,000
Industrial Research Assistance Program …
Oct. 1, 2023 - Sept. 30, 2026Evaluation of SARS-Cov-2 testing platforms for on-site testing of Airport Passe… Major Funding
Greater Toronto Airports Authority
Toronto, ON 2021-22
The GTAA will evaluate various SARS-CoV-2 diagnostic tests of domestic and international passengers on arrival and departure including airport employ…
$6,097,280
Industrial Research Assistance Program …
Nov. 23, 2020 - July 31, 2022Evaluation of SARS-Cov-2 testing platforms for on-site testing of Airport Passe… Major Funding
Greater Toronto Airports Authority
Toronto, ON 2021-22
The GTAA will evaluate various SARS-CoV-2 diagnostic tests of domestic and international passengers on arrival and departure including airport employ…
$6,097,280
Industrial Research Assistance Program …
Nov. 23, 2020 - March 31, 2022Next-Generation Autonomous Robotic Cleaning Systems Platform Major Funding
Avidbots Corp.
Kitchener, ON 2023-24
Avidbots has ambitious growth goals in 2024 and we plan to run a series of R&D and Business Innovation projects to accomplish them. Both the technica…
$6,013,020
Industrial Research Assistance Program …
Aug. 1, 2023 - Sept. 30, 2024Design, development and testing of the next generation energy storage systems Major Funding
Corvus Energy Inc.
Richmond, BC 2021-22
Develop and test multi-megawatt, modular, compact energy storage systems with multi-layered fully integrated controls and management information syst…
$6,000,000
Industrial Research Assistance Program …
Oct. 1, 2019 - March 18, 2022COVID-19 Response (VI): DPX-COVID-19 Clinical Development and DPX-CoVLP Proof-o… Major Funding
ImmunoVaccine Technologies Inc.
Dartmouth, NS 2021-22
In response to the global crisis, IMV has initiated the development of a vaccine to protect against the COVID-19 pandemic. We believe our targeted pe…
$5,887,037
Industrial Research Assistance Program …
Sept. 4, 2020 - March 31, 2022COVID-19 Response (VI): DPX-COVID-19 Clinical Development Major Funding
ImmunoVaccine Technologies Inc.
Dartmouth, NS 2020-21
In response to the global crisis, IMV has initiated the development of a vaccine to protect against the COVID-19 pandemic. We believe our targeted pe…
$5,887,037
Industrial Research Assistance Program …
Sept. 4, 2020 - Sept. 30, 2021Programme dacclration daffaires dentreprises innovantes forte croissance pour … Major Funding
Corporation inno-Centre du Qubec
Montreal, QC 2018-19
Dmarcher, slectionner et encadrer des entreprises technologiques en dmarrage fort potentiel commercial, ayant atteint le stade de la commercialisati…
$5,850,584
Canada Accelerator and Incubator Program
June 1, 2014 - March 31, 2019Evaluation of SARS-Cov-2 testing platforms for on-site testing of Airport Passe… Major Funding
Greater Toronto Airports Authority
Toronto, ON 2021-22
The GTAA will evaluate various SARS-CoV-2 diagnostic tests of domestic and international passengers on arrival and departure including airport employ…
$5,690,280
Industrial Research Assistance Program …
Nov. 23, 2020 - Sept. 30, 2021Rponse la COVID-19 (VI) - First phase of testing in humans Major Funding
Pharma Glycovax Inc
Montreal, QC 2021-22
Using O-glycan biomarkers, a vaccine against Covid-19 virus will be confirmed as non-toxic and then tested at the clinical level (phase I).
$5,612,600
Industrial Research Assistance Program …
Aug. 31, 2020 - July 16, 2022New Robotic Platform for Medical Purpose Major Funding
Kinova inc
Boisbriand, QC 2023-24
The development and deployment of robotic solutions remain a major challenge for most companies, regardless of the markets. Kinova intends to address…
$5,600,000
Industrial Research Assistance Program …
Sept. 18, 2023 - March 31, 2026Design, development and testing of the next generation energy storage systems Major Funding
Corvus Energy Inc.
Richmond, BC 2020-21
Develop and test multi-megawatt, modular, compact energy storage systems with multi-layered fully integrated controls and management information syst…
$5,600,000
Industrial Research Assistance Program …
Oct. 1, 2019 - March 18, 2022Rponse la COVID-19 (VI) - First phase of testing in humans Major Funding
Pharma Glycovax Inc
Montreal, QC 2021-22
Using O-glycan biomarkers, a vaccine against Covid-19 virus will be confirmed as non-toxic and then tested at the clinical level (phase I).
$5,552,600
Industrial Research Assistance Program …
Aug. 31, 2020 - March 15, 2022COVID-19 Rapid Response: Assessment of the Effect of lung-directed Site-Specifi… Major Funding
Qu Biologics Inc.
Burnaby, BC 2023-24
#####################################################################################################################################################…
$5,426,172
Industrial Research Assistance Program …
Sept. 1, 2022 - March 31, 2024COVID-19 Response (VI): DPX-COVID-19 Clinical Development Major Funding
ImmunoVaccine Technologies Inc.
Dartmouth, NS 2020-21
In response to the global crisis, IMV has initiated the development of a vaccine to protect against the COVID-19 pandemic. We believe our targeted pe…
$5,412,045
Industrial Research Assistance Program …
Sept. 4, 2020 - March 31, 2021Digital Fraud Detection and Risk Scoring Product Major Funding
Trulioo Information Services Inc.
Vancouver, BC 2023-24
Software development project to develop a new digital product that will provide an instantaneous first assessment of potential fraud with an associat…
$5,229,998
Industrial Research Assistance Program …
April 1, 2022 - Sept. 30, 2024COVID-19 Vaccine: Phase 2 clinical trial of DNA-based vaccine Covigenix VAX-001 Major Funding
Entos Pharmaceuticals Inc.
Edmonton, AB 2021-22
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In t…
$5,200,000
Industrial Research Assistance Program …
Nov. 1, 2021 - Dec. 31, 2022COVID-19 Vaccine: Phase 2 clinical trial of DNA-based vaccine Covigenix VAX-001 Major Funding
Entos Pharmaceuticals Inc.
Edmonton, AB 2021-22
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In t…
$5,200,000
Industrial Research Assistance Program …
Nov. 1, 2021 - March 31, 2022COVID-19 Vaccine: Phase 1 clinical trial of DNA-based vaccine Covigenix VAX-001 Major Funding
Entos Pharmaceuticals Inc.
Edmonton, AB 2020-21
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In t…
$5,200,000
Industrial Research Assistance Program …
Sept. 1, 2020 - May 31, 2021Evaluation of SARS-Cov-2 testing platforms for on-site testing of Airport Passe… Major Funding
Greater Toronto Airports Authority
Toronto, ON 2020-21
The GTAA will evaluate various SARS-CoV-2 diagnostic tests of domestic and international passengers on arrival and departure including airport employ…
$5,190,280
Industrial Research Assistance Program …
Nov. 23, 2020 - July 31, 2021Interactive Visits at Technology Access Centres Major Funding
Tech-Access Canada
Ottawa, ON 2021-22
Tech-Access Canada will deliver an Interactive Visit program to enable SMEs to access the specialized innovation services of a Technology Access Cent…
$5,155,000
Industrial Research Assistance Program …
April 1, 2021 - March 31, 2023COVID-19 Vaccine: Phase 1 clinical trial of DNA-based vaccine Covigenix VAX-001 Major Funding
Entos Pharmaceuticals Inc.
Edmonton, AB 2020-21
Entos has developed Covigenix VAX-001, a DNA Proteo-Lipid Vehicle (PLV) vaccine intended for the prevention of COVID-19 infection by SARS-CoV-2. In t…
$5,000,000
Industrial Research Assistance Program …
Sept. 1, 2020 - March 31, 2021COVID-19 VI Providence Major Funding
Providence Therapeutics Holdings Inc.
Calgary, AB 2020-21
Providence Therapeutics, Canada?s leading mRNA vaccine manufacture, is manufacturing an mRNA vaccine against COVID-19. The company is in the R&D phas…
$4,700,000
Industrial Research Assistance Program …
Sept. 1, 2020 - Aug. 31, 2021COVID-19 Response: Development of novel COVID-19 Therapeutics utilizing Precisi… Major Funding
JN NOVA PHARMA INC
Montreal, QC 2021-22
Development of a proprietary biological drug to block Coronavirus infectivity, whilst reducing induced pathology in symptomatic patients, permitting …
$4,609,000
Industrial Research Assistance Program …
Oct. 5, 2020 - Jan. 31, 2023COVID-19 Response: Development of novel COVID-19 Therapeutics utilizing Precisi… Major Funding
JN NOVA PHARMA INC
Montreal, QC 2021-22
Development of a proprietary biological drug to block Coronavirus infectivity, whilst reducing induced pathology in symptomatic patients, permitting …
$4,609,000
Industrial Research Assistance Program …
Oct. 5, 2020 - March 31, 2022COVID-19 Response: Development of novel COVID-19 Therapeutics utilizing Precisi… Major Funding
JN NOVA PHARMA INC
Montreal, QC 2020-21
Development of a proprietary biological drug to block Coronavirus infectivity, whilst reducing induced pathology in symptomatic patients, permitting …
$4,609,000
Industrial Research Assistance Program …
Oct. 5, 2020 - Nov. 26, 2021COVID-19 Response (VI): STAGE 2 Oral DNA Vaccine Development Major Funding
Symvivo Corporation
Burnaby, BC 2021-22
This project will involve further development and characterization of oral bacTRL-based vaccines. This work includes the preclinical development of …
$4,571,774
Industrial Research Assistance Program …
June 1, 2021 - June 30, 2022COVID-19 Response (VI): STAGE 2 Oral DNA Vaccine Development Major Funding
Symvivo Corporation
Burnaby, BC 2021-22
This project will involve further development and characterization of oral bacTRL-based vaccines. This work includes the preclinical development of …
$4,571,774
Industrial Research Assistance Program …
June 1, 2021 - March 18, 2022COVID-19 Response (TI): antivrial & Inflammation Controlling Therapeutic Drug C… Major Funding
Laurent Pharmaceuticals Inc.
Montreal, QC 2020-21
Clinical development of LAU-7b antiviral and inflammation-controlling therapy for COVID-19 infection.
$4,166,796
Industrial Research Assistance Program …
Oct. 1, 2020 - Sept. 30, 2021LSALT Drug Development program to mitigate COVID-19 related Organ (Lung and Kid… Major Funding
Arch Biopartners Inc.
Toronto, ON 2023-24
The project targets the prevention of acute organ inflammation injury in the lungs and kidneys of patients who have moderate to severe COVID-19 and o…
$4,000,000
Industrial Research Assistance Program …
Nov. 1, 2022 - March 31, 2024Transformational Financial Crime Detection Major Funding
Verafin Solutions ULC
St. John's, NL 2021-22
Verafin will transform the financial crime detection industry by utilizing new technologies in our cloud environment to help the Firm design, develop…
$4,000,000
Industrial Research Assistance Program …
Oct. 28, 2019 - Oct. 31, 2022